StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

MiMedx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MiMedx's price to sales ratio was 1.4× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.2× to 4.1×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×−1.2
2025Dec 31, 20252.5×−1.6
2024Dec 31, 20244.1×+0.8
2023Dec 29, 20233.3×+2.0
2022Dec 30, 20221.3×−1.3
2021Dec 31, 20212.6×−1.4
2020Dec 31, 20203.9×+1.3
2019Dec 31, 20192.7×+2.1
2018Dec 31, 20180.6×−4.1
2017Dec 29, 20174.6×+0.3
2016Dec 30, 20164.3×−1.6
2015Dec 31, 20155.8×−6.9
2014Dec 31, 201412.8×−3.8
2013Dec 31, 201316.5×−0.9
2012Dec 31, 201217.4×+3.8
2011Dec 30, 201113.6×–

More MiMedx figures

See a number that looks wrong?